Interview 3 Sep 2025 Radiopharma’s big year: Interview with RadioMedix CEO Dr. Delpassand As radiopharma is gaining momentum, read our interview with Dr. Delpassand, the CEO of RadioMedix’s, an established company of the field. September 3, 2025 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 1 Sep 2025 Blood Cancer Awareness Month: What biotech holds in store As September marks the beginning of Blood Cancer Awareness Month, delve into what is being developed in the biotech pipelines. September 1, 2025 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
More News! 27 Aug 2025 Zemcelpro, the first blood cord expansion therapy to reach the EU market Find out about ExCellThera’s zemcelpro, the first blood cord expansion therapy to reach the European market, and only the second globally. August 27, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 22 Aug 2025 The Sanofi pipeline in 2025: Is the play-to-win strategy working? Find out what Sanofi has been up to in 2025, especially as it just closed the Opella deal and is now expanding its pipeline. August 22, 2025 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 20 Aug 2025 From pasture to lab: The new biotech toolkit for cattle Nature writes the best horror stories – In The New York Times’ recent piece, the return of the screwworm, a flesh‑eating parasite once eradicated from the U.S. Indeed, cattle ranchers are once again staring at wounds riddled with maggots. This insect, which devastated cattle in the 20th century, is making a comeback, spurring governments to […] August 20, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 15 Aug 2025 How biotech is improving the life of your cat About a week ago, on August 8th, fell International Cat Day. Even if you are a cat person like I am, you might have missed the event. Don’t worry, your feline probably didn’t know about it either. In this article, we will take a look at what biotech is doing in cat health. While the cat […] August 15, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 24 Jul 2025 Which biotech companies are gaining traction in genetic diseases? Discover twelve companies focused on genetic diseases that managed to close funding rounds in the last two years. July 24, 2025 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 23 Jul 2025 Biotech stars of 2024, did they shine or fade in 2025? Find out if the biotech companies Labiotech designated as the ones to keep an eye on in 2024 held up to our expectation in 2025. July 23, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 18 Jul 2025 Hyderabad’s Genome Valley, biopharma’s scale-up hub Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and gene therapy. July 18, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 18 Jul 2025Taking the fight to inflammatory disease: InflaRx’s first-in-class C5a/C5aR signaling pathway strategy This week, I talked to Niels Riedemann, CEO and Founder of InflaRx, about his company’s first-in-class approach to fighting inflammation. July 18, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 10 Jul 2025 Radiopharma’s new wave: Nuclidium and Actithera raise the stakes Take a closer look at the radiopharma new wave as Nuclidium and Actithera raise big to develop their platforms. July 10, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 9 Jul 2025 New hope for CIPN: Can emerging therapies ease chemotherapy’s nerve damage? Delve into the growing field of CIPN, the most common side effect of chemotherapy, as we are getting closer to a first approval. July 9, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email